Risk factors and intervention strategies for lower extremity deep vein thrombosis after intravenous thrombolysis for acute ischemic stroke - Report - MDSpire
Advertisement
Risk factors and intervention strategies for lower extremity deep vein thrombosis after intravenous thrombolysis for acute ischemic stroke
Factors Influencing Lower Extremity Deep Vein Thrombosis Risk and Prophylactic Approaches Following Intravenous Thrombolysis in Acute Ischemic Stroke Patients
Overview
This study identifies a significant association between the absence of early pharmacological thromboprophylaxis and the incidence of in-hospital DVT in acute ischemic stroke patients treated with intravenous thrombolysis. Key factors influencing the initiation of prophylaxis include atrial fibrillation, stroke severity, and elevated D-dimer levels.
Background
Acute ischemic stroke (AIS) is a leading cause of mortality and disability, with a high risk of venous thromboembolism (VTE) among affected patients. The use of intravenous thrombolysis (IVT) is critical in the hyperacute phase of AIS, yet it also increases the risk of complications such as lower extremity deep vein thrombosis (LEDVT). Understanding the factors that influence thromboprophylaxis is important.
Data Highlights
Characteristic
Value
Patients with early prophylaxis
118 (59.9%)
Patients without early prophylaxis
79 (40.1%)
In-hospital DVT incidence
32 (16.2%)
DVT incidence with early prophylaxis
6.8%
DVT incidence without early prophylaxis
30.4%
Adjusted odds ratio for DVT without prophylaxis
3.16 (95% CI 1.19–8.42)
Key Findings
Absence of early pharmacological thromboprophylaxis is associated with higher odds of in-hospital DVT.
DVT occurred in 30.4% of patients without early prophylaxis compared to 6.8% with prophylaxis.
Factors associated with non-initiation of early prophylaxis include atrial fibrillation and higher NIHSS scores.
Patients with higher D-dimer levels were less likely to receive early prophylaxis.
A risk-treatment paradox was observed, where patients at higher thrombotic risk received less prophylaxis.
Clinical Implications
Clinicians should be aware of the increased risk of DVT in AIS patients who do not receive early pharmacological prophylaxis.
Conclusion
The findings highlight a significant gap in thromboprophylaxis practices among AIS patients treated with IVT.